Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress

Chris Ward, Nicola Curry, Magdy El-Ekiaby, Kerstin Jurk, Henri H. Versteeg, Charithani Keragala, Tal Burstyn-Cohen, Silvio Antoniak, Yuko Suzuki, Ross I. Baker, Olivier Christophe, Shoshana Revel-Vilk, Alice Hart, Carsten Deppermann, Huyen Tran, Nicola Pozzi, Walter H.A. Kahr, Steven P. Grover, Philip Wenzel, Ashley C. BrownCécile Oury, Susan M. Shea, James Fredenburgh, Freda H. Passam, James Winearls, Hunter B. Moore, Soumitra Tole, Eileen Merriman, Geoffrey D. Barnes, Z. Leonardo Liu, Michelle Sholzberg

Research output: Contribution to journalArticlepeer-review

Abstract

Here, we present a series of illustrated capsules from the State of the Art (SOA) speakers at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand. This year's Congress marks the first time that the International Society on Thrombosis and Haemostasis has held its flagship scientific meeting in Southeast Asia and is the first to be organized by an international Planning Committee. The Bangkok program will feature innovative science and clinical updates from around the world, reflecting the diversity and multidisciplinary growth of our field. In these illustrated SOA capsules, you will find an exploration of novel models of thrombosis and bleeding and biomaterial discoveries that can trigger or block coagulation. Thromboinflammation is now understood to drive many disease states, and the SOA speakers cover cellular and coagulation responses to COVID-19 and other infections. The theme of crosstalk between coagulation and inflammation expands with capsules on protein S signaling, complement, and fibrinolytic inhibitors. Novel agents for hemophilia and thrombosis prevention are introduced. Challenging clinical conditions are also covered, such as inherited platelet disorders and antiphospholipid antibody syndrome. The scientific program in Bangkok will also showcase the work of clinicians and scientists from all parts of the world and chronicle real-world challenges. For example, 2 SOA capsules address the diagnosis and management of von Willebrand disease in low-income settings. Take some time to browse through these short illustrated reviews; we're sure that you'll be entertained, educated, and inspired to further explore the world of thrombosis and hemostasis.

Original languageAmerican English
Article number102432
JournalResearch and Practice in Thrombosis and Haemostasis
Volume8
Issue number4
DOIs
StatePublished - May 2024

Bibliographical note

Publisher Copyright:
© 2024 The Authors

Cite this